Carlos Gallardo Araneda
0000-0001-6516-395X
Bradford Hill
1 paper found
Refreshing results…
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial
Missing publications? Search for publications with a matching author name.